(Q51555848)

English

Continuous systemic corticosteroids do not affect the ongoing regression of metastatic melanoma for more than two years following ipilimumab therapy.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/20593249

Continuous systemic corticosteroids do not affect the ongoing regression of metastatic melanoma for more than two years following ipilimumab therapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/20593249

metastatic melanoma

1 reference

based on heuristic

inferred from title

author name string

Kaan Harmankaya

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/20593249

Christa Erasim

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/20593249

Claus Koelblinger

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/20593249

Ramy Ibrahim

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/20593249

Axel Hoos

5

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/20593249

Hubert Pehamberger

6

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/20593249

Michael Binder

7

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/20593249

publication date

1 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/20593249

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/20593249

28

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/20593249

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/20593249

1140-1144

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/20593249

Management of metastatic melanoma 2005.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9606-0

21 January 2018

Next generation of immunotherapy for melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9606-0

21 January 2018

Current systemic therapy for metastatic melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9606-0

21 January 2018

Anti-cytotoxic T-lymphocyte antigen-4 antibody: the first in an emerging class of immunomodulatory antibodies for cancer treatment

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9606-0

21 January 2018

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9606-0

21 January 2018

A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9606-0

21 January 2018

Human chorionic gonadotropin in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9606-0

21 January 2018

Detection of beta-human chorionic gonadotropin mRNA as a marker for cutaneous malignant melanoma.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9606-0

21 January 2018

Human chorionic gonadotropin-beta subunit gene expression in cultured human fetal and cancer cells of different types and origins.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9606-0

21 January 2018

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9606-0

21 January 2018

Phase I/II study of ipilimumab for patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9606-0

21 January 2018

Review: anti-CTLA-4 antibody ipilimumab: case studies of clinical response and immune-related adverse events

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9606-0

21 January 2018

Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9606-0

21 January 2018

Have we found the "definitive cancer biomarker"? The diagnostic and therapeutic implications of human chorionic gonadotropin-beta expression as a key to malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20593249

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 30-year-old woman with melanoma metastases and a positive pregnancy test

1 reference

https://pubmed.ncbi.nlm.nih.gov/20593249

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20593249

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20593249

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-010-9606-0

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/20593249

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/20593249

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51555848&oldid=2210899366"